US4457867A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Physiologically active peptide
Assignee: Asahi Kasei Corp
•
Filing: 1982-12-17
•
Granted: 1984-07-03
•
Expires: 2002-12-17
Abstract
Abstract A novel physiologically active peptide represented by the following formula: BCysX.sub.1 CysX.sub.2 CysX.sub.3 (wherein B stands for a hydrogen atom or a methionyl group, Cys a cysteine residue, X 1 5 to 9 amino acid residues, X 2 one amino acid residue, and X 3 138 to 148 amino acid residues), which is excellent in physiological activities such as antiviral action, cell proliferation inhibitive action and NK (natural killer) cell activity enhancing action.
Inventors
- 👤 Torao Ishida
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 18:32
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/80; C12N15/81; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/555; C07K14/57; A; A61; A61K; A61K38/00; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/14; Y10S930/142
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
52 words
A physiologically active peptide represented by the following formula (I): BCysX.sub.1 CysX.sub.2 CysX.sub.3 (I) wherein B stands for a hydrogen atom or a methionyl group, Cys a cysteine residue, X 1 5 to 9 amino acid residues, X 2 one amino acid residue, and X 3 138 to 148 amino acid residues.
Claim 2
Dependent Claim
52 words
A physiologically active peptide represented by the following formula (I): BCysX.sub.1 CysX.sub.2 CysX.sub.3 (I) wherein B stands for a hydrogen atom or a methionyl group, Cys a cysteine residue, X 1 5 to 9 amino acid residues, X 2 one amino acid residue, and X 3 138 to 148 amino acid residues.
Claim 3
Dependent Claim
24 words
A peptide according to claim 1, wherein X 1 stands for 7 amino acid residues and X 3 stands for 143 amino acid residues.
Claim 4
Dependent Claim
26 words
A peptide according to any of claims 1 or 2, wherein X 1 stands for an isoleucylvalylleucylglycylserylleucylglycine residue and X 2 stands for a tyrosine residue.
Claim 5
Dependent Claim
112 words
A peptide according to claim 1, wherein X 1 stands for an isoleucylvalylleucylglycylserylleucylglycine residue, X 2 stands for a tyrosine residue and X 3 stands for a residue represented by the following formula (II): Gln Asp Pro Tyr Val Lys Glu Ala Glu Asn Leu Lys Lys Tyr Phe Asn Ala Gly His Ser Asp Val Ala Asp Asn Gly Thr Leu Phe Leu Gly Ile Leu Lys Asn Trp Lys Glu Glu Ser Asp Arg Lys Ile Met Gln Ser Gln Ile Val Ser Phe Tyr Phe Lys Leu Phe Lys Asn Phe Lys Asp Asp Gln Ser Ile Gln Lys Ser Val Glu Thr Ile Lys Glu Asp Met Asn
Claim 6
Dependent Claim
147 words
Val Lys Phe Phe Asn Ser Asn Lys Lys Lys Arg Asp Asp Phe Glu Lys Leu Thr Asn Tyr Ser Val Thr Asp Leu Asn Val Gln Arg Lys Ala Ile His Glu Leu Ile Gln Val Met Ala Glu Leu Ser Pro Ala Ala Lys Thr Gly Lys Arg Lys Arg Ser Gln Met Leu Phe Arg Gly Arg Arg Ala Ser Gln wherein Gln stands for a glutamine residue, Asp an aspartic acid residue, Pro a proline residue, Tyr a tyrosine residue, Val a valine residue, Lys a lysine residue, Glu a glutamic acid residue, Ala an alanine residue, Asn an asparagine residue, Leu a leucine residue, Phe a phenylalanine residue, Gly a glycine residue, His a histidine residue, Ser a serine residue, Thr a threonine residue, Ile an isoleucine residue, Trp a tryptophan residue, Arg an arginine residue, and Met a methionine residue.
Claim 7
Dependent Claim
147 words
Val Lys Phe Phe Asn Ser Asn Lys Lys Lys Arg Asp Asp Phe Glu Lys Leu Thr Asn Tyr Ser Val Thr Asp Leu Asn Val Gln Arg Lys Ala Ile His Glu Leu Ile Gln Val Met Ala Glu Leu Ser Pro Ala Ala Lys Thr Gly Lys Arg Lys Arg Ser Gln Met Leu Phe Arg Gly Arg Arg Ala Ser Gln wherein Gln stands for a glutamine residue, Asp an aspartic acid residue, Pro a proline residue, Tyr a tyrosine residue, Val a valine residue, Lys a lysine residue, Glu a glutamic acid residue, Ala an alanine residue, Asn an asparagine residue, Leu a leucine residue, Phe a phenylalanine residue, Gly a glycine residue, His a histidine residue, Ser a serine residue, Thr a threonine residue, Ile an isoleucine residue, Trp a tryptophan residue, Arg an arginine residue, and Met a methionine residue.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-07-03 | 1988-01-02 | 1988-07-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-07-03 | 1992-01-02 | 1992-07-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-07-03 | 1996-01-02 | 1996-07-03 | $7700.00 | Window Closed / Lapsed |